Fulgent Genetics, Inc.
FLGT
$19.45
-$0.45-2.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.95% | -6.01% | -254.39% | 65.14% | -64.41% |
| Total Depreciation and Amortization | 27.93% | -1.83% | 1.23% | -0.26% | 2.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.81% | -15.72% | 17.00% | -56.27% | 93.68% |
| Change in Net Operating Assets | -193.28% | 123.37% | -3,107.97% | 106.19% | -293.39% |
| Cash from Operations | -434.76% | 109.08% | -803.55% | 136.81% | -580.91% |
| Capital Expenditure | 25.84% | -4.46% | 17.69% | 11.37% | -44.68% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -100.00% | -- | -100.00% |
| Cash Acquisitions | 100.00% | -- | -100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.77% | 344.40% | -24.45% | -64.54% | 85.64% |
| Cash from Investing | 364.40% | -1.93% | -41.55% | -64.26% | 92.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 84.40% | -540.91% | 0.00% | 0.00% | 85.48% |
| Issuance of Common Stock | -77.78% | 800.00% | -- | -- | -- |
| Repurchase of Common Stock | 45.48% | -9,805.59% | -25.21% | 86.00% | 75.87% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45.97% | -8,295.69% | -20.00% | 83.13% | 76.39% |
| Foreign Exchange rate Adjustments | 2,833.33% | -96.00% | 400.00% | 275.00% | -63.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.85% | 60.27% | -326.63% | 44.48% | 69.72% |